​

Funding Round

Series B - NeRRe Therapeutics

Series B - NeRRe Therapeutics

Investment Firm

Overview

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.

Announced Date

Jan 05, 2017

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorFountain Healthcare Partners
Participant InvestorForbion Capital Partners
Participant InvestorOrbiMed
Participant InvestorNovo Holdings
Participant InvestorAdvent Life Sciences

Round Details and Background

NeRRe Therapeutics raised $28569902 on 2017-01-05 in Series B

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 07, 2021
Series B - NeRRe Therapeutics
6-27.6M
Jan 05, 2017
Series B - NeRRe Therapeutics
5-28.6M
Dec 19, 2012
Series A - NeRRe Therapeutics
3-18.4M

Recent Activity

There is no recent news or activity for this profile.